Genedrive PLC - ESG Rating & Company Profile powered by AI
This report of Genedrive PLC uses data from across the web as well as from public disclosures by Genedrive PLC. If you work at Genedrive PLC and you would like to licence your ESG rating, please get in touch. This webpage displays a free Sustainability analysis for Genedrive PLC.
Genedrive PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.2; made up of an environmental score of 8.0, social score of 5.3 and governance score of 5.3.
6.2
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
427 | Scancell Holdings PLC | 6.3 | High |
427 | Verastem Inc | 6.3 | High |
450 | Genedrive PLC | 6.2 | High |
450 | Cannasouth Ltd | 6.2 | High |
450 | CareDx International AB | 6.2 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Genedrive PLC have an accelerator or VC vehicle to help deliver innovation?
Does Genedrive PLC disclose current and historical energy intensity?
Does Genedrive PLC report the average age of the workforce?
Does Genedrive PLC reference operational or capital allocation in relation to climate change?
Does Genedrive PLC disclose its ethnicity pay gap?
Does Genedrive PLC disclose cybersecurity risks?
Does Genedrive PLC offer flexible work?
Does Genedrive PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Genedrive PLC disclose the number of employees in R&D functions?
Does Genedrive PLC conduct supply chain audits?
Does Genedrive PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Genedrive PLC conduct 360 degree staff reviews?
Does Genedrive PLC disclose the individual responsible for D&I?
Does Genedrive PLC disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Genedrive PLC disclose current and / or historical scope 2 emissions?
Does Genedrive PLC disclose water use targets?
Does Genedrive PLC have careers partnerships with academic institutions?
Did Genedrive PLC have a product recall in the last two years?
Does Genedrive PLC disclose incidents of discrimination?
Does Genedrive PLC allow for Work Councils/Collective Agreements to be formed?
Has Genedrive PLC issued a profit warning in the past 24 months?
Does Genedrive PLC disclose parental leave metrics?
Does Genedrive PLC disclose climate scenario or pathway analysis?
Does Genedrive PLC disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Genedrive PLC disclose the pay ratio of women to men?
Does Genedrive PLC support suppliers with sustainability related research and development?
Does Genedrive PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Genedrive PLC reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Genedrive PLC involved in embryonic stem cell research?
Does Genedrive PLC disclose GHG and Air Emissions intensity?
Does Genedrive PLC disclose its waste policy?
Does Genedrive PLC report according to TCFD requirements?
Does Genedrive PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Genedrive PLC disclose energy use targets?
Does Genedrive PLC disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Genedrive PLC have a policy relating to cyber security?
Have a different question?
Potential Risks for Genedrive PLC
These potential risks are based on the size, segment and geographies of the company.
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive, a patented small polymerase chain reaction, which enables rapid nucleic acid amplification and detection from various sample types, including plasma, sputum, and buccal swabs. Its Genedrive platform offers Genedrive HCV ID Kit, a qualitative molecular solution for Hepatitis C Virus testing; Genedrive BioPlex for the rapid determination of military biothreats from pathogens; Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and Genedrive Connect app, an android-based mobile app that allows added data management flexibility and results transmission. The company serves biotechnology and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. It has a collaboration agreement with Beckman Coulter Life Sciences to automate the laboratory PCR testing process for COVID-19. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.